In addition, the recently identified small molecule inhibitor of TMPRSS2, N-0385, inhibited SARS-CoV-2 infection in human lung cells and showed the high efficiency of prophylactic and therapeutic benefits in the transgenic mouse model of severe COVID-19 [105]. This evidence concerns the gene TMPRSS2 and COVID-19.